Commentary: Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention
J Clin Psychiatry 2013;74(2):167-169
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
According to the authors, the very considerable morbidity and dysfunction associated with childhood-onset bipolar illness make early identification and treatment a very high but elusive priority. There are few studies identifying optimal treatment for children with bipolar I disorder, and treatment options for children with bipolar II disorder and bipolar disorder not otherwise specified are rare. The authors suggest that children at high and ultrahigh risk for childhood-onset bipolar disorder can be identified on clinical grounds and that practical clinical trials with large populations, similar to those studying cancer therapies, could be implemented at low cost.